Skip to main content
Equibles

FF · "FINE FOODS & PHARMACEUTICALS N.T.M. S.P.A." · Financials

Use FF with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research FF.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
7.0200 EUR +0.1200 (+1.74%) At close · Oct 6
Rebalance outlook locked
Market Cap
159.66M EUR
Shares
22.49M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →

Browse captured authority reports and their original financial labels

Revenue
253.46M +3.4%
FY2025 Revenue FY2021–FY2025
Net Income
10.1M +23.8%
FY2025 Net Income FY2021–FY2025
Operating Margin
6.48% +0.5pp
FY2025 Operating Margin FY2021–FY2025
Operating Cash Flow
31.76M -30.7%
FY2025 Operating Cash Flow FY2021–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2025 FY2024 FY2023 FY2022 FY2021
EUR 253.46M 245.07M 252.91M 208.32M 195.24M
EUR 18.02M 15.78M 21.2M 16.42M 14.53M
EUR 16.42M 14.64M 1.07M -1.01M 5.03M
EUR 3.05M 3.5M 4.96M 2.25M 763.31K
EUR 13.57M 11.83M -1.86M -14.2M -4.59M
EUR 3.47M 3.68M 1.67M -4.7M -3.16M
EUR 10.1M 8.16M -3.52M -9.5M -1.43M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2021–FY2025: 15.89M in dividends.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current lease liabilities 2025-12-31 EUR 390,589 ESEF Annual Report filed 2026-04-07
Noncurrent lease liabilities 2025-12-31 EUR 899,666 ESEF Annual Report filed 2026-04-07
Noncurrent long-term borrowings 2025-12-31 EUR 72,736,116 ESEF Annual Report filed 2026-04-07
Short-term borrowings 2025-12-31 EUR 12,752,615 ESEF Annual Report filed 2026-04-07
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.